abstract |
The invention relates to compounds of formula (I): n n n n n n n n n n n n wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists. |